United States - English - NLM (National Library of Medicine)

chiesi usa, inc. - poractant alfa (unii: ke3u2023np) (poractant alfa - unii:ke3u2023np) - poractant alfa 80 mg in 1 ml - curosurf® (poractant alfa) intratracheal suspension is indicated for the rescue treatment of respiratory distress syndrome (rds) in premature infants.  curosurf reduces mortality and pneumothoraces associated with rds.  none. the safety and effectiveness of curosurf for the rescue treatment, including the reduction of mortality and pneumothoraces, of respiratory distress syndrome (rds) have been established in premature infants and the information on this use is discussed throughout the labeling. the safety and effectiveness of curosurf in the treatment of full term infants or older pediatric patients with respiratory failure has not been established.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - poractant alfa, quantity: 80 mg/ml - suspension - excipient ingredients: sodium chloride; water for injections; sodium bicarbonate - for the treatment (rescue) of respiratory distress syndrome (rds) in premature infants and for prophylactic use in infants at risk of rds.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - poractant alfa, quantity: 80 mg/ml - suspension - excipient ingredients: sodium chloride; water for injections; sodium bicarbonate - for the treatment (rescue) of respiratory distress syndrome (rds) in premature infants and prophylactic use in infants at risk of rds.

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - cefquinome sulphate - cefquinome sulphate 9.38 g/kg - antibiotic

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - cefquinome sulphate - cefquinome sulphate 25 g/kg - antibiotic

Israel - English - Ministry of Health

intervet ( israel) ltd - cefquinome as sulfate - suspension for injection - cefquinome as sulfate 25 mg/ml - for the treatment of infections diseases caused by microorganisms susceptible to cefquinome in cattle and pigs.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teofarma s.r.l. - nifedipine - modified-release capsule - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teofarma s.r.l. - nifedipine - modified-release capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teofarma s.r.l. - nifedipine - modified-release capsule - 30mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teofarma s.r.l. - nifedipine - modified-release capsule - 60mg